Supreme Court temporarily extends access to abortion pill mifepristone

Key Points:

• The Supreme Court has temporarily blocked restrictions on the abortion pill mifepristone, allowing continued access through pharmacies and mail while the court reviews the case, with a decision expected by Thursday.
• The case originates from Louisiana's lawsuit aiming to roll back FDA rules on mifepristone prescriptions, arguing the drug's availability undermines the state's abortion ban and questioning its safety, despite FDA approval since 2000.
• Medication abortions, primarily using mifepristone and misoprostol, accounted for nearly two-thirds of U.S. abortions in 2023, highlighting the pill's widespread use and the significance of the court's decision.
• This dispute echoes a similar case three years ago, where the Supreme Court blocked restrictions on mifepristone access, and the current case has drawn input from medical groups, pharmaceutical companies, and lawmakers cautioning against limiting access.
• The Trump administration has notably remained silent in this case, creating ambiguity given its political ties to anti-abortion groups, while Justice Samuel Alito, who blocked the restrictions, has been a key figure in abortion-related rulings.